"could it be that Leo and Dr. B are considering OM development by IPIX?"
I never know what they're thinking but I pay careful attention to what they say and don't say. Others, some who are less careful, can connect the dots (even when there is no dot)....I'm no good at that.
Here's all I'm saying:
According to the PR there is "a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications" in the non-binding term sheet. The press release DOES NOT SAY, either by intent or what I would consider to be extraordinary neglect, that one of the "other Gastrointestinal (GI) indications" is Oral Mucositis.
"could it be that Leo and Dr. B are considering OM development by IPIX?"
That's one of a number of possible takeaways.